Stem Cell Network (SCN)
SCN supports cutting-edge projects that translate Canadian stem cell research discoveries into new and better treatments.
- Company typePrivate
- Founded2001
- HeadquartersOttawa, Canada
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Stem Cell Network (SCN) does
Supporting and building Canada’s stem cell and regenerative medicine research sector has been the raison d’être of the Stem Cell Network (SCN) since its inception in 2001. Its work has been supported by the Government of Canada from the beginning. In just over 16 years, SCN has forged a national community that has transformed stem cell research in Canada, brought research to the point where regenerative medicine is changing clinical practice, and established an outstanding international reputation. SCN has pushed the boundaries of what was a basic research area towards translational outcomes for the clinic and marketplace.
Stem Cell Network (SCN) firmographics
Firmographics- Name
- Stem Cell Network (SCN)
- Legal name
- Stem Cell Network
- Website
- https://stemcellnetwork.ca/
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SCN supports cutting-edge projects that translate Canadian stem cell research discoveries into new and better treatments.
- Ownership category
- akta.pro rank
Stem Cell Network (SCN) industry classification
Industry- Product category
- Regenerative Medicine Research Funding
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Health Services (8000), Services-Educational Services (8200)
- akta.pro primary industry
- Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE)
- akta.pro secondary industries
- Stem Cell–Based Regenerative Therapies (HLAAAGAA), STEM, Digital Literacy & Maker Education Nonprofits (BPAGADAG), STEM & Maker Education (Makerspaces, Coding Clubs, Robotics) (EDAAAFAL)
Keywords
Where Stem Cell Network (SCN) is headquartered
LocationHeadquarters
- HQ city
- Ottawa
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Stem Cell Network (SCN) business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Government of Canada Funding: The Stem Cell Network receives government funding to support its mission of advancing stem cell and regenerative medicine research in Canada. The Government of Canada invested $45 million for the 2022-2025 period, demonstrating ongoing commitment to the network's activities.
- Partnership Funding: SCN leverages partnership funding from organizations like Breakthrough T1D to co-fund research projects, expanding the total investment in Canadian regenerative medicine research.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Stem Cell Network (SCN) product offering
Product offeringCore offering
Stem Cell Network is a Canadian national not-for-profit organization that supports cutting-edge projects translating stem cell research discoveries into new treatments. It does this by operating competitive research funding programs for translational regenerative medicine, training programs for highly qualified personnel, the annual Till & McCulloch Meetings conference, and outreach initiatives such as StemCellTalks. Recipients—academic researchers, trainees, and Canadian biotech companies—receive funding, training, and convening services at no cost, funded primarily through Government of Canada grants and partnership co-funding.
Product overview
The Stem Cell Network (SCN) is a Canadian national not-for-profit organization that functions as a multi-faceted platform supporting stem cell and regenerative medicine research. Rather than a single unified product, SCN offers an integrated ecosystem comprising: research funding programs supporting translational regenerative medicine across the research continuum; training programs including the Foundations Course, Fellowships, Internships & Exchanges, and Summer Studentships; the Till & McCulloch Meetings (TMM) as Canada's premier stem cell and regenerative medicine conference; the StemCellTalks outreach initiative for high school students; the SCN-RDMM Catalyst Grant for rare disease research; the Incubation Investment Award for biotech companies; and a Funded Research Database. Together, these offerings span the full pipeline from discovery research through clinical translation to commercialization and public engagement.
Differentiator
Problem solved
Functional benefit
Products and services
- Research Funding Programs
- Incubation Investment Award
- SCN-RDMM Catalyst Grant Catalyst grant program connecting researchers and clinicians to advance rare disease discovery and mechanistic research through the Rare Diseases: Models & Mechanisms (RDMM) network.
- Fellowships, Internships & Exchanges Training program offering fellowships, internships, and research exchanges that help graduate students, postdoctoral fellows, and other trainees gain skills for careers in regenerative medicine.
- Foundations Course Foundational training course building essential skills for success in regenerative medicine research, aimed at new trainees entering the field.
- Summer Studentships Summer research studentships providing paid research opportunities for undergraduate students exploring careers in regenerative medicine.
- Till & McCulloch Meetings (TMM) Annual conference that is Canada's premier stem cell and regenerative medicine meeting, bringing together scientists, students, industry experts, and policy scholars for plenaries, breakouts, networking, and the Cells I See art contest.
- Funded Research Database Public, searchable database of all SCN-funded research projects and clinical trials since 2016, supporting transparency and researcher discovery.
- StemCellTalks
Quantifiable outcome
- More than 25 clinical trials supported
- +2 more outcomes
Companies that use Stem Cell Network (SCN)
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
Stem Cell Network (SCN) technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Stem Cell Network (SCN) partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Breakthrough T1D (formerly JDRF)corePartnership to fund four Canadian research projects focused on cell replacement therapies for type 1 diabetes, running from May 2025 to April 2027. The partnership is part of SCN's broader $33 million investment supporting 36 regenerative medicine research projects and clinical trials. Projects include preclinical development of a manufactured islet replacement product by Vancouver-based Lunar Therapeutics, and research on islet cryopreservation, encapsulation devices, and human immune system models.
Scale indicators9 records
Recent moves5 records
Expansion highlights5 records
Stem Cell Network (SCN) competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Stem Cell Network (SCN) social profiles
Digital presenceStem Cell Network (SCN) financial estimates
Financial estimateRevenue estimate
Valuation estimate
Stem Cell Network (SCN) leadership team
Management profileNumber of profiles
Profiles6 records
Stem Cell Network (SCN) funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Stem Cell Network (SCN) M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Stem Cell Network (SCN)
What does Stem Cell Network (SCN) do?
Stem Cell Network is a Canadian national not-for-profit organization that supports cutting-edge projects translating stem cell research discoveries into new treatments. It does this by operating competitive research funding programs for translational regenerative medicine, training programs for highly qualified personnel, the annual Till & McCulloch Meetings conference, and outreach initiatives such as StemCellTalks. Recipients—academic researchers, trainees, and Canadian biotech companies—receive funding, training, and convening services at no cost, funded primarily through Government of Canada grants and partnership co-funding.
Is Stem Cell Network (SCN) a public or private company?
Stem Cell Network (SCN) is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Stem Cell Network (SCN) founded?
Stem Cell Network (SCN) was founded in 2001. It employs 1 to 10 people.
Where is Stem Cell Network (SCN) based?
Stem Cell Network (SCN) is headquartered in Ottawa, Canada, in the North America region.
How does Stem Cell Network (SCN) make money?
Two revenue lines are on record. Government of Canada Funding is the primary driver. The others are partnership Funding.
Does Stem Cell Network (SCN) have an API?
No public API is recorded for Stem Cell Network (SCN).
What industry is Stem Cell Network (SCN) in?
Stem Cell Network (SCN)'s product category is Regenerative Medicine Research Funding. Its primary akta.pro industry code is HLAAABAE, Stem Cell Therapies (MSC/iPSC/HSC-derived), with a secondary code of HLAAAGAA, Stem Cell–Based Regenerative Therapies. Its NAICS code is 541714 and its SIC code is 8000.